BDNF signaling and survival of striatal neurons

Frontiers in Cellular Neuroscience

Volumn 8, Issue AUG, 2014, Pages

  Baydyuk, Maryna ^a   Xu, Baoji ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

BDNF; Dopaminergic neurons; DRD1a; DRD2; Huntington's disease; Neurotrophins; Striatum; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NEUROTROPHIN 3;

AMNESIA; BRAIN ATROPHY; BRAIN DEVELOPMENT; BRAIN NERVE CELL; BRAIN SIZE; CELL MATURATION; CELL SURVIVAL; COGNITIVE DEFECT; CORPUS STRIATUM; DRUG TARGETING; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUNTINGTON CHOREA; MOTOR COORDINATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE FUNCTION; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84928757930     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00254     Document Type: Review

References (106)

1. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., and Timmusk, T. (2007). Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525-535. doi: 10.1002/jnr.21139
2. Alcántara, S., Frisén, J., Del Río, J. A., Soriano, E., Barbacid, M., and Silos-Santiago, I. (1997). TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. J. Neurosci. 17, 3623-3633.
3. Altar, C. A., Cai, N., Bliven, T., Juhasz, M., Conner, J. M., Acheson, A. L., et al. (1997). Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389, 856-860. doi: 10.1038/39885
4. Anderson, S. A., Qiu, M., Bulfone, A., Eisenstat, D. D., Meneses, J., Pedersen, R., et al. (1997). Mutations of the homeobox genes Dlx-1 and Dlx-2 disrupt the striatal subventricular zone and differentiation of late born striatal neurons. Neuron 19, 27-37. doi: 10.1016/s0896-6273(00)80345-1
5. Apostol, B. L., Simmons, D. A., Zuccato, C., Illes, K., Pallos, J., Casale, M., et al. (2008). CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice. Mol. Cell. Neurosci. 39, 8-20. doi: 10.1016/j.mcn.2008.04.007
6. Baquet, Z. C., Gorski, J. A., and Jones, K. R. (2004). Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J. Neurosci. 24, 4250-4258. doi: 10.1523/jneurosci.3920-03.2004
7. Bartkowska, K., Paquin, A., Gauthier, A. S., Kaplan, D. R., and Miller, F. D. (2007). Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. Development 134, 4369-4380. doi: 10.1242/dev.008227
8. Bath, K. G., Akins, M. R., and Lee, F. S. (2011). BDNF control of adult SVZ neurogenesis. Dev. Psychobiol. 54, 578-589. doi: 10.1002/dev.20546
9. Baydyuk, M., Russell, T., Liao, G. Y., Zang, K., An, J. J., Reichardt, L. F., et al. (2011). TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons. Proc. Natl. Acad. Sci. U S A 108, 1669-1674. doi: 10.1073/pnas.1004744108
10. Baydyuk, M., Xie, Y., Tessarollo, L., and Xu, B. (2013). Midbrain-derived neurotrophins support survival of immature striatal projection neurons. J. Neurosci. 33, 3363-3369. doi: 10.1523/JNEUROSCI.3687-12.2013
11. Besusso, D., Geibel, M., Kramer, D., Schneider, T., Pendolino, V., Picconi, B., et al. (2013). BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior. Nat. Commun. 4:2031. doi: 10.1038/ncomms3031
12. Bhave, S. V., Ghoda, L., and Hoffman, P. L. (1999). Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. J. Neurosci.19, 3277-3286.
13. Block-Galarza, J., Chase, K. O., Sapp, E., Vaughn, K. T., Vallee, R. B., DiFiglia, M., et al. (1997). Fast transport and retrograde movement of huntingtin and HAP 1 in axons. Neuroreport 8, 2247-2251. doi: 10.1097/00001756-199707070-00031
14. Bolam, J. P., Hanley, J. J., Booth, P. A., and Bevan, M. D. (2000). Synaptic organisation of the basal ganglia. J. Anat.196, 527-542. doi: 10.1046/j.1469-7580.2000.19640527.x
15. Borrell-Pagès, M., Zala, D., Humbert, S., and Saudou, F. (2006). Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies. Cell. Mol. Life Sci. 63, 2642-2660. doi: 10.1007/s00018-006-6242-0
16. Calabresi, P., Centonze, D., Gubellini, P., Marfia, G. A., Pisani, A., Sancesario, G., et al. (2000). Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol. 61, 231-265. doi: 10.1016/s0301-0082(99)00030-1
17. Canals, J. M., Pineda, J. R., Torres-Peraza, J. F., Bosch, M., Martin-Ibanez, R., Munoz, M. T., et al. (2004). Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci. 24, 7727-7739. doi: 10.1523/jneurosci.1197-04.2004
18. Casarosa, S., Fode, C., and Guillemot, F. (1999). Mash1 regulates neurogenesis in the ventral telencephalon. Development 126, 525-534.
19. Cattaneo, E. (2003). Dysfunction of wild-type huntingtin in Huntington disease. News Physiol. Sci. 18, 34-37. doi: 10.1152/nips.01410.2002
20. Chao, M. V. (2003). Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309. doi: 10.1038/nrn1078
21. Cho, S. R., Benraiss, A., Chmielnicki, E., Samdani, A., Economides, A., and Goldman, S. A. (2007). Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease. J. Clin. Invest. 117, 2889-2902. doi: 10.1172/jci31778
22. Christensen, J., Sorensen, J. C., Ostergaard, K., and Zimmer, J. (1999). Early postnatal development of the rat corticostriatal pathway: an anterograde axonal tracing study using biocytin pellets. Anat. Embryol. (Berl) 200, 73-80. doi: 10.1007/s004290050261
23. Ciammola, A., Sassone, J., Cannella, M., Calza, S., Poletti, B., Frati, L., et al. (2007). Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B, 574-577. doi: 10.1002/ajmg.b.30501
24. Cohen, M. S., Bas Orth, C., Kim, H. J., Jeon, N. L., and Jaffrey, S. R. (2011). Neurotrophin-mediated dendrite-to-nucleus signaling revealed by microfluidic compartmentalization of dendrites. Proc. Natl. Acad. Sci. U S A 108, 11246-11251. doi: 10.1073/pnas.1012401108
25. Conner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., and Varon, S. (1997). Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17, 2295-2313.
26. Coppola, V., Kucera, J., Palko, M. E., Martinez-De Velasco, J., Lyons, W. E., Fritzsch, B., et al. (2001). Dissection of NT3 functions in vivo by gene replacement strategy. Development 128, 4315-4327.
27. Corbin, J. G., Gaiano, N., Machold, R. P., Langston, A., and Fishell, G. (2000). The Gsh2 homeodomain gene controls multiple aspects of telencephalic development. Development 127, 5007-5020.
28. Crowley, C., Spencer, S. D., Nishimura, M. C., Chen, K. S., Pitts-Meek, S., Armanini, M. P., et al. (1994). Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76, 1001-1011. doi: 10.1016/0092-8674(94)90378-6
29. Cummings, D. M., Andre, V. M., Uzgil, B. O., Gee, S. M., Fisher, Y. E., Cepeda, C., et al. (2009). Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J. Neurosci. 29, 10371-10386. doi: 10.1523/JNEUROSCI.1592-09.2009
30. Curtis, M. A., Penney, E. B., Pearson, A. G., van Roon-Mom, W. M., Butterworth, N. J., Dragunow, M., et al. (2003). Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc. Natl. Acad. Sci. U S A 100, 9023-9027. doi: 10.1073/pnas.1532244100
31. Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., et al. (2006). Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9, 251-259. doi: 10.1038/nn1632
32. Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X. J., and Mattson, M. P. (2003). Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression and increases survival in huntingtin mutant mice. Proc. Natl. Acad. Sci. U S A 100, 2911-2916. doi: 10.1073/pnas.0536856100
33. Encinas, M., Iglesias, M., Llecha, N., and Comella, J. X. (1999). Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem. 73, 1409-1421. doi: 10.1046/j.1471-4159.1999.0731409.x
34. Engelender, S., Sharp, A. H., Colomer, V., Tokito, M. K., Lanahan, A., Worley, P., et al. (1997). Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 6, 2205-2212. doi: 10.1093/hmg/6.13.2205
35. Fariñas, I., Jones, K. R., Tessarollo, L., Vigers, A. J., Huang, E., Kirstein, M., et al. (2001). Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J. Neurosci. 21, 6170-6180.
36. Fariñas, I., Wilkinson, G. A., Backus, C., Reichardt, L. F., and Patapoutian, A. (1998). Characterization of neurotrophin and Trk receptor functions in developing sensory ganglia: direct NT-3 activation of TrkB neurons in vivo. Neuron 21, 325-334. doi: 10.1016/s0896-6273(00)80542-5
37. Fariñas, I., Yoshida, C. K., Backus, C., and Reichardt, L. F. (1996). Lack of neurotrophin-3 results in death of spinal sensory neurons and premature differentiation of their precursors. Neuron 17, 1065-1078. doi: 10.1016/s0896-6273(00)80240-8
38. Ferrante, R. J., Beal, M. F., Kowall, N. W., Richardson, E. P. Jr., and Martin, J. B. (1987a). Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 411, 162-166. doi: 10.1016/0006-8993(87)90694-9
39. Ferrante, R. J., Kowall, N. W., Beal, M. F., Martin, J. B., Bird, E. D., Richardson, E. P. Jr., et al. (1987b). Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46, 12-27. doi: 10.1097/00005072-198701000-00002
40. Ferrer, I., Goutan, E., Marin, C., Rey, M. J., and Ribalta, T. (2000). Brain-derived neurotrophic factor in Huntington disease. Brain Res. 866, 257-261. doi: 10.1016/s0006-8993(00)02237-x
41. Gauthier, L. R., Charrin, B. C., Borrell-Pages, M., Dompierre, J. P., Rangone, H., Cordelieres, F. P., et al. (2004). Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127-138. doi: 10.1016/j.cell.2004.06.018
42. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J. Jr., et al. (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432. doi: 10.1126/science.2147780
43. Gerfen, C. R., Miyachi, S., Paletzki, R., and Brown, P. (2002). D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 22, 5042-5054.
44. Gharami, K., Xie, Y., An, J. J., Tonegawa, S., and Xu, B. (2008). Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J. Neurochem. 105, 369-379. doi: 10.1111/j.1471-4159.2007.05137.x
45. Gil, J. M., Mohapel, P., Araujo, I. M., Popovic, N., Li, J. Y., Brundin, P., et al. (2005). Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol. Dis. 20, 744-751. doi: 10.1016/j.nbd.2005.05.006
46. Gorski, J. A., Zeiler, S. R., Tamowski, S., and Jones, K. R. (2003). Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J. Neurosci. 23, 6856-6865.
47. Gusella, J. F., and MacDonald, M. E. (2000). Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci. 1, 109-115. doi: 10.1038/35039051
48. Ha, J., Lo, K. W., Myers, K. R., Carr, T. M., Humsi, M. K., Rasoul, B. A., et al. (2008). A neuron-specific cytoplasmic dynein isoform preferentially transports TrkB signaling endosomes. J. Cell Biol. 181, 1027-1039. doi: 10.1083/jcb.200803150
49. Hamasaki, T., Goto, S., Nishikawa, S., and Ushio, Y. (2003). Neuronal cell migration for the developmental formation of the mammalian striatum. Brain Res. Brain Res. Rev. 41, 1-12. doi: 10.1016/s0165-0173(02)00216-3
50. Heerssen, H. M., Pazyra, M. F., and Segal, R. A. (2004). Dynein motors transport activated Trks to promote survival of target-dependent neurons. Nat. Neurosci. 7, 596-604. doi: 10.1038/nn1242
51. Henry, R. A., Hughes, S. M., and Connor, B. (2007). AAV-mediated delivery of BDNF augments neurogenesis in the normal and quinolinic acid-lesioned adult rat brain. Eur. J. Neurosci. 25, 3513-3525. doi: 10.1111/j.1460-9568.2007.05625.x
52. Ho, A. K., Sahakian, B. J., Brown, R. G., Barker, R. A., Hodges, J. R., Ane, M. N., et al. (2003). Profile of cognitive progression in early Huntington's disease. Neurology 61, 1702-1706. doi: 10.1212/01.wnl.0000098878.47789.bd
53. Hu, Z., Cooper, M., Crockett, D. P., and Zhou, R. (2004). Differentiation of the midbrain dopaminergic pathways during mouse development. J. Comp. Neurol. 476, 301-311. doi: 10.1002/cne.20230
54. Huang, Z. J., Kirkwood, A., Pizzorusso, T., Porciatti, V., Morales, B., Bear, M. F., et al. (1999). BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98, 739-755. doi: 10.1016/s0092-8674(00)81509-3
55. Kawaguchi, Y. (1997). Neostriatal cell subtypes and their functional roles. Neurosci. Res. 27, 1-8. doi: 10.1016/s0168-0102(96)01134-0
56. Klein, R., Martin-Zanca, D., Barbacid, M., and Parada, L. F. (1990). Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system. Development 109, 845-850.
57. Lawrence, A. D., Hodges, J. R., Rosser, A. E., Kershaw, A., Ffrench-Constant, C., Rubinsztein, D. C., et al. (1998). Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121(Pt. 7), 1329-1341. doi: 10.1093/brain/121.7.1329
58. Li, S. H., Gutekunst, C. A., Hersch, S. M., and Li, X. J. (1998). Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 18, 1261-1269.
59. Li, Y., Yui, D., Luikart, B. W., McKay, R. M., Li, Y., Rubenstein, J. L., et al. (2012). Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development. Proc. Natl. Acad. Sci. U S A 109, 15491-15496. doi: 10.1073/pnas.1212899109
60. Liot, G., Zala, D., Pla, P., Mottet, G., Piel, M., and Saudou, F. (2013). Mutant huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J. Neurosci. 33, 6298-6309. doi: 10.1523/jneurosci.2033-12.2013
61. Lynch, G., Kramar, E. A., Rex, C. S., Jia, Y., Chappas, D., Gall, C. M., et al. (2007). Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J. Neurosci. 27, 4424-4434. doi: 10.1523/jneurosci.5113-06.2007
62. Mann, D. M., Oliver, R., and Snowden, J. S. (1993). The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol. 85, 553-559. doi: 10.1007/BF00230496
63. Marchand, R., and Lajoie, L. (1986). Histogenesis of the striopallidal system in the rat. Neurogenesis of its neurons. Neuroscience 17, 573-590. doi: 10.1016/0306-4522(86)90031-x
64. Mazarakis, N. K., Cybulska-Klosowicz, A., Grote, H., Pang, T., Van Dellen, A., Kossut, M., et al. (2005). Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice. J. Neurosci. 25, 3059-3066. doi: 10.1523/jneurosci.4320-04.2005
65. McAllister, A. K., Katz, L. C., and Lo, D. C. (1999). Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 22, 295-318. doi: 10.1146/annurev.neuro.22.1.295
66. Metsis, M., Timmusk, T., Arenas, E., and Persson, H. (1993). Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc. Natl. Acad. Sci. U S A 90, 8802-8806. doi: 10.1073/pnas.90.19.8802
67. Minichiello, L., and Klein, R. (1996). TrkB and TrkC neurotrophin receptors cooperate in promoting survival of hippocampal and cerebellar granule neurons. Genes Dev. 10, 2849-2858. doi: 10.1101/gad.10.22.2849
68. Mink, J. W., and Thach, W. T. (1993). Basal ganglia intrinsic circuits and their role in behavior. Curr. Opin. Neurobiol. 3, 950-957. doi: 10.1016/0959-4388(93)90167-w
69. Murphy, K. P., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., et al. (2000). Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci. 20, 5115-5123.
70. Nisenbaum, L. K., Webster, S. M., Chang, S. L., McQueeney, K. D., and Loturco, J. J. (1998). Early patterning of prelimbic cortical axons to the striatal patch compartment in the neonatal mouse. Dev. Neurosci. 20, 113-124. doi: 10.1159/000017307
71. Ohtani, N., Goto, T., Waeber, C., and Bhide, P. G. (2003). Dopamine modulates cell cycle in the lateral ganglionic eminence. J. Neurosci. 23, 2840-2850.
72. Olsson, M., Bjorklund, A., and Campbell, K. (1998). Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence. Neuroscience 84, 867-876. doi: 10.1016/s0306-4522(97)00532-0
73. Olsson, M., Campbell, K., Wictorin, K., and Bjorklund, A. (1995). Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience 69, 1169-1182. doi: 10.1016/0306-4522(95)00325-d
74. Orefice, L. L., Waterhouse, E. G., Partridge, J. G., Lalchandani, R. R., Vicini, S., and Xu, B. (2013). Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines. J. Neurosci. 33, 11618-11632. doi: 10.1523/JNEUROSCI.0012-13.2013
75. Parent, A., and Hazrati, L. N. (1995). Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Brain Res. Rev. 20, 91-127. doi: 10.1016/0165-0173(94)00007-c
76. Pattabiraman, P. P., Tropea, D., Chiaruttini, C., Tongiorgi, E., Cattaneo, A., and Domenici, L. (2005). Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo. Mol. Cell. Neurosci. 28, 556-570. doi: 10.1016/j.mcn.2004.11.010
77. Peng, Q., Masuda, N., Jiang, M., Li, Q., Zhao, M., Ross, C. A., et al. (2008). The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp. Neurol. 210, 154-163. doi: 10.1016/j.expneurol.2007.10.015
78. Phillips, W., Morton, A. J., and Barker, R. A. (2005). Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment. J. Neurosci. 25, 11564-11576. doi: 10.1523/jneurosci.3796-05.2005
79. Poo, M. M. (2001). Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2, 24-32. doi: 10.1038/35049004
80. Rauskolb, S., Zagrebelsky, M., Dreznjak, A., Deogracias, R., Matsumoto, T., Wiese, S., et al. (2010). Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J. Neurosci. 30, 1739-1749. doi: 10.1523/JNEUROSCI.5100-09.2010
81. Reichardt, L. F. (2006). Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1545-1564. doi: 10.1098/rstb.2006.1894
82. Reiner, A., Albin, R. L., Anderson, K. D., D'Amato, C. J., Penney, J. B., and Young, A. B. (1988). Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. U S A 85, 5733-5737. doi: 10.1073/pnas.85.15.5733
83. Scharfman, H., Goodman, J., Macleod, A., Phani, S., Antonelli, C., and Croll, S. (2005). Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. Exp. Neurol. 192, 348-356. doi: 10.1016/j.expneurol.2004.11.016
84. Segal, R. A. (2003). Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 26, 299-330. doi: 10.1146/annurev.neuro.26.041002.131421
85. Shuen, J. A., Chen, M., Gloss, B., and Calakos, N. (2008). Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia. J. Neurosci. 28, 2681-2685. doi: 10.1523/JNEUROSCI.5492-07.2008
86. Simmons, D. A., Rex, C. S., Palmer, L., Pandyarajan, V., Fedulov, V., Gall, C. M., et al. (2009). Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc. Natl. Acad. Sci. U S A 106, 4906-4911. doi: 10.1073/pnas.0811228106
87. Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A., et al. (1994). Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368, 246-249. doi: 10.1038/368246a0
88. Spires, T. L., Grote, H. E., Varshney, N. K., Cordery, P. M., Van Dellen, A., Blakemore, C., et al. (2004). Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J. Neurosci. 24, 2270-2276. doi: 10.1523/jneurosci.1658-03.2004
89. Stenman, J., Toresson, H., and Campbell, K. (2003). Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis. J. Neurosci. 23, 167-174.
90. Strand, A. D., Baquet, Z. C., Aragaki, A. K., Holmans, P., Yang, L., Cleren, C., et al. (2007). Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J. Neurosci. 27, 11758-11768. doi: 10.1523/jneurosci.2461-07.2007
91. Svenningsson, P., Nishi, A., Fisone, G., Girault, J. A., Nairn, A. C., and Greengard, P. (2004). DARPP-32: an integrator of neurotransmission. Annu. Rev. Pharmacol. Toxicol. 44, 269-296. doi: 10.1146/annurev.pharmtox.44.101802.121415
92. Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., et al. (1993). Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475-489. doi: 10.1016/0896-6273(93)90335-o
93. Van Raamsdonk, J. M., Pearson, J., Slow, E. J., Hossain, S. M., Leavitt, B. R., and Hayden, M. R. (2005). Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci. 25, 4169-4180. doi: 10.1523/jneurosci.0590-05.2005
94. Vonsattel, J. P., and DiFiglia, M. (1998). Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384.
95. Voorn, P., Kalsbeek, A., Jorritsma-Byham, B., and Groenewegen, H. J. (1988). The pre-and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25, 857-887. doi: 10.1016/0306-4522(88)90041-3
96. Watson, F. L., Heerssen, H. M., Moheban, D. B., Lin, M. Z., Sauvageot, C. M., Bhattacharyya, A., et al. (1999). Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J. Neurosci. 19, 7889-7900.
97. Xie, Y., Hayden, M. R., and Xu, B. (2010). BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice. J. Neurosci. 30, 14708-14718. doi: 10.1523/JNEUROSCI.1637-10.2010
98. Xu, B., Gottschalk, W., Chow, A., Wilson, R. I., Schnell, E., Zang, K., et al. (2000a). The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J. Neurosci. 20, 6888-6897.
99. Xu, B., Zang, K., Ruff, N. L., Zhang, Y. A., Mcconnell, S. K., Stryker, M. P., et al. (2000b). Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB. Neuron 26, 233-245. doi: 10.1016/S0896-6273(00)81153-8
100. Yamada, M., Ohnishi, H., Sano, S., Araki, T., Nakatani, A., Ikeuchi, T., et al. (1999). Brain-derived neurotrophic factor stimulates interactions of Shp2 with phosphatidylinositol 3-kinase and Grb2 in cultured cerebral cortical neurons. J. Neurochem. 73, 41-49. doi: 10.1046/j.1471-4159.1999.0730041.x
101. Yamada, M., Suzuki, K., Mizutani, M., Asada, A., Matozaki, T., Ikeuchi, T., et al. (2001). Analysis of tyrosine phosphorylation-dependent protein-protein interactions in trkb-mediated intracellular signaling using modified yeast two-hybrid system. J. Biochem. 130, 157-165. doi: 10.1093/oxfordjournals.jbchem.a002955
102. Yan, Q., Radeke, M. J., Matheson, C. R., Talvenheimo, J., Welcher, A. A., and Feinstein, S. C. (1997). Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J. Comp. Neurol. 378, 135-157. doi: 10.1002/(SICI)1096-9861(19970203)378:1<135::AID-CNE8>3.0.CO;2-5
103. Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., et al. (2001). Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498. doi: 10.1126/science.1059581
104. Zuccato, C., Marullo, M., Conforti, P., Macdonald, M. E., Tartari, M., and Cattaneo, E. (2008). Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol. 18, 225-238. doi: 10.1111/j.1750-3639.2007.00111.x
105. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., et al. (2003). Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76-83. doi: 10.1038/ng1219
106. Zweifel, L. S., Kuruvilla, R., and Ginty, D. D. (2005). Functions and mechanisms of retrograde neurotrophin signalling. Nat. Rev. Neurosci. 6, 615-625. doi: 10.1038/nrn1727